Jaguar Health, Inc.
(NASDAQ : JAGX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.91%139.371.9%$325.68m
TEVATeva Pharmaceutical Industries Ltd. -3.02%12.532.0%$167.10m
MYLMylan NV -1.04%17.073.2%$119.63m
BBIOBridgeBio Pharma, Inc. -16.46%29.330.0%$16.53m
RDYDr. Reddy's Laboratories Ltd. 3.97%53.462.0%$12.52m
TXMDTherapeuticsMD, Inc. -3.42%1.1322.1%$6.40m
ABEOAbeona Therapeutics, Inc. 2.16%3.314.5%$3.87m
TAROTaro Pharmaceutical Industries Ltd. -1.46%68.066.5%$2.13m
COCPCocrystal Pharma, Inc. 0.08%0.970.0%$1.80m
JAGXJaguar Health, Inc. 14.29%0.482.0%$1.65m
LFVNLifeVantage Corp. 0.92%15.313.3%$1.58m
KINKindred Biosciences, Inc. -2.50%4.290.3%$1.46m
CPHIChina Pharma Holdings, Inc. -3.80%0.450.1%$0.55m

Company Profile

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.